Arif Kamal, Chief Patient Officer of American Cancer Society and President of American Academy of Hospice and Palliative Medicine, shared a post on LinkedIn:
“Meaningful advances in cancer prevention are driven by partners willing to lead together.
One year ago, the American Cancer Society launched ACS CancerRisk360 – with the support of Pfizer, including my close colleagues Marianne Gandee, Cozi Namer, and Judy Sewards – to elevate awareness, expand reach, and bring cancer risk conversations to the forefront. This visibility has translated into strong engagement with CancerRisk360, demonstrating that when access improves, action follows.
Today, that collaboration continues to evolve. Pfizer has launched its own frontline risk assessment tool, designed as a first step that connects seamlessly into the full ACS CancerRisk360 experience.
This National Cancer Prevention Month, we celebrate prevention progress that meets people where they are and helps them take the next steps with confidence!
Start with Pfizer‘s 30-second assessment, then follow the prompt for the full ACS CancerRisk360 assessment.”
Other articles featuring ACS on OncoDaily.